[1] |
Weiszfeiler G, Karasseva V, Karczag E. A new mycobacterium species: Mycobacterium asiaticum n.sp. Acta Microbiol Acad Sci Hung, 1971, 18(4):247-252.
pmid: 5006093
|
[2] |
Blacklock ZM, Dawson DJ, Kane DW, et al. Mycobacterium asiaticum as a potential pulmonary pathogen for humans. A clinical and bacteriologic review of five cases. Am Rev Respir Dis, 1983, 127(2): 241-244. doi:10.1164/arrd.1983.127.2.241.
|
[3] |
Arttawejkul P, Kongpolprom N. A case of pulmonary infection caused by Mycobacterium asiaticum: Difficulties on diagnostic and therapeutic approaches. Respir Med Case Rep, 2018, 24:150-152. doi:10.1016/j.rmcr.2018.05.014.
pmid: 29984149
|
[4] |
Wayne LG, Sramek HA. Agents of newly recognized or infrequently encountered mycobacterial diseases. Clin Microbiol Rev, 1992, 5(1):1-25. doi:10.1128/CMR.5.1.1.
pmid: 1735092
|
[5] |
Grech M, Carter R, Thomson R. Clinical significance of Mycobacterium asiaticum isolates in Queensland, Australia. J Clin Microbiol, 2010, 48(1):162-167. doi:10.1128/JCM.01602-09.
|
[6] |
杨松, 郭建琼, 王乐乐, 等. 《少见非结核分枝杆菌肺病治疗共识与推荐》解读. 中华结核和呼吸杂志, 2023, 46(5): 547-550. doi:10.3760/cma.j.cn112147-20220711-00587.
|
[7] |
中华人民共和国国家卫生和计划生育委员会. WS 288—2017肺结核诊断. 2017-11-09.
|
[8] |
World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization, 2020.
|
[9] |
World Health Organization. WHO consolidated guidelines on drug-resistant tuberculosis treatment. Geneva: World Health Organization, 2019.
|
[10] |
初乃惠, 周文强. 耐药结核病的诊治进展. 中华传染病杂志, 2021, 39(7): 385-391. doi:10.3760/cma.j.cn311365-20210414-00133.
|
[11] |
Taylor LQ, Williams AJ, Santiago S. Pulmonary disease caused by Mycobacterium asiaticum. Tubercle, 1990, 71(4):303-305. doi:10.1016/0041-3879(90)90047-c.
pmid: 2267684
|
[12] |
Grech M, Carter R, Thomson R. Clinical significance of Mycobacterium asiaticum isolates in Queensland, Australia. J Clin Microbiol, 2010, 48(1):162-167. doi:10.1128/JCM.01602-09.
|
[13] |
Almukhtar T, AlMajali A, Bhatti H, et al. Mycobacterium asiaticum renaissance: what to do? Chest, 2016, 150 (4): 172A. doi:10.1016/j.chest.2016.08.181.
|
[14] |
中华医学会结核病学分会. 非结核分枝杆菌病诊断与治疗指南(2020年版). 中华结核和呼吸杂志, 2020, 43(11):918-946. doi:10.3760/cma.j.cn112147-20200508-00570.
|
[15] |
Cowman S, van Ingen J, Griffith DE, et al. Non-tuberculous mycobacterial pulmonary disease. Eur Respir J, 2019, 54(1):1900250. doi:10.1183/13993003.00250-2019.
|
[16] |
Dahl VN, Mølhave M, Fløe A, et al. Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review. Int J Infect Dis, 2022, 125:120-131. doi:10.1016/j.ijid.2022.10.013.
pmid: 36244600
|